
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Perspectives on the Clinical Development of NRF2-Targeting Drugs
Diego Lastra, Raquel Fernández-Ginés, Gina Manda, et al.
Handbook of experimental pharmacology (2020), pp. 93-141
Closed Access | Times Cited: 23
Diego Lastra, Raquel Fernández-Ginés, Gina Manda, et al.
Handbook of experimental pharmacology (2020), pp. 93-141
Closed Access | Times Cited: 23
Showing 23 citing articles:
Dimethyl Fumarate Alleviates NLRP3 Inflammasome Activation in Microglia and Sickness Behavior in LPS-Challenged Mice
Bora Tastan, Burak I. Ariöz, Kemal Uğur Tüfekçi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
Bora Tastan, Burak I. Ariöz, Kemal Uğur Tüfekçi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
Brain-Protective Mechanisms of Transcription Factor NRF2: Toward a Common Strategy for Neurodegenerative Diseases
Antonio Cuadrado
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 255-277
Open Access | Times Cited: 61
Antonio Cuadrado
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 255-277
Open Access | Times Cited: 61
Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
Bora Tastan, Burak I. Ariöz, Şermin Genç
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Bora Tastan, Burak I. Ariöz, Şermin Genç
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Emodin, a Potent Anthraquinone Mitigates MPTP-Induced Parkinsons’ Disease Pathology by Regulating Nrf2 and Its Downstream Targets: In Silico and In Vivo Approach
Sarwat Jahan, Muhammad Ikram, Sami Siraj, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Sarwat Jahan, Muhammad Ikram, Sami Siraj, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access | Times Cited: 1
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access | Times Cited: 1
Procyanidin B2 ameliorates endothelial dysfunction and impaired angiogenesis via the Nrf2/PPARγ/sFlt-1 axis in preeclampsia
Lei Liu, Rencheng Wang, Ran Xu, et al.
Pharmacological Research (2022) Vol. 177, pp. 106127-106127
Closed Access | Times Cited: 26
Lei Liu, Rencheng Wang, Ran Xu, et al.
Pharmacological Research (2022) Vol. 177, pp. 106127-106127
Closed Access | Times Cited: 26
Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders
Jed W. Fahey, Hua Liu, Holly Batt, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1353-1353
Open Access
Jed W. Fahey, Hua Liu, Holly Batt, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1353-1353
Open Access
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis
Olmo Martín-Cámara, Marina Arribas, Geoffrey Wells, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 1867-1882
Open Access | Times Cited: 17
Olmo Martín-Cámara, Marina Arribas, Geoffrey Wells, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 1867-1882
Open Access | Times Cited: 17
Nrf2 Protein Serum Concentration in Human CKD Shows a Biphasic Behavior
Marianne Rasmussen, Kristian Horsman Hansen, Alexandra Scholze
Antioxidants (2023) Vol. 12, Iss. 4, pp. 932-932
Open Access | Times Cited: 10
Marianne Rasmussen, Kristian Horsman Hansen, Alexandra Scholze
Antioxidants (2023) Vol. 12, Iss. 4, pp. 932-932
Open Access | Times Cited: 10
An insight into the concept of neuroinflammation and neurodegeneration in Alzheimer’s disease: targeting molecular approach Nrf2, NF-κB, and CREB
Shaveta Bhardwaj, Amarjot Kaur Grewal, Shamsher Singh, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2943-2960
Closed Access | Times Cited: 3
Shaveta Bhardwaj, Amarjot Kaur Grewal, Shamsher Singh, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2943-2960
Closed Access | Times Cited: 3
Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders
Mohammad Amin Bayat Tork, Soroush Fotouhi, Parvin Roozi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Mohammad Amin Bayat Tork, Soroush Fotouhi, Parvin Roozi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Reactive Oxygen Species
Harald Schmidt, Pietro Ghezzi, Antonio Cuadrado
Handbook of experimental pharmacology (2021)
Closed Access | Times Cited: 22
Harald Schmidt, Pietro Ghezzi, Antonio Cuadrado
Handbook of experimental pharmacology (2021)
Closed Access | Times Cited: 22
Exploring the Conformational Landscape of the Neh4 and Neh5 Domains of Nrf2 Using Two Different Force Fields and Circular Dichroism
Megan Chang, Carter J. Wilson, Nadun C. Karunatilleke, et al.
Journal of Chemical Theory and Computation (2021) Vol. 17, Iss. 5, pp. 3145-3156
Closed Access | Times Cited: 21
Megan Chang, Carter J. Wilson, Nadun C. Karunatilleke, et al.
Journal of Chemical Theory and Computation (2021) Vol. 17, Iss. 5, pp. 3145-3156
Closed Access | Times Cited: 21
α-Lipoic Acid Targeting PDK1/NRF2 Axis Contributes to the Apoptosis Effect of Lung Cancer Cells
Liduo Yue, Yanbei Ren, Qingxi Yue, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 17
Liduo Yue, Yanbei Ren, Qingxi Yue, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 17
Emodin Prevented Depression in Chronic Unpredicted Mild Stress-Exposed Rats by Targeting miR-139-5p/5-Lipoxygenase
Teng Zhang, Can Yang, Jiang Chu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 16
Teng Zhang, Can Yang, Jiang Chu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 16
Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19
Joe M. McCord, Brooks M. Hybertson, Adela Cota‐Gomez, et al.
Free Radical Biology and Medicine (2021) Vol. 175, pp. 56-64
Open Access | Times Cited: 16
Joe M. McCord, Brooks M. Hybertson, Adela Cota‐Gomez, et al.
Free Radical Biology and Medicine (2021) Vol. 175, pp. 56-64
Open Access | Times Cited: 16
Therapeutic Effects of Resveratrol in Inflammatory Bowel Diseases: Shedding Light on the Role of Cellular and Molecular Pathways
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, et al.
Revista Brasileira de Farmacognosia (2022) Vol. 32, Iss. 2, pp. 160-173
Closed Access | Times Cited: 8
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, et al.
Revista Brasileira de Farmacognosia (2022) Vol. 32, Iss. 2, pp. 160-173
Closed Access | Times Cited: 8
Development of targeted therapy of NRF2high esophageal squamous cell carcinoma
Chorlada Paiboonrungruang, Emily J. Simpson, Zhaohui Xiong, et al.
Cellular Signalling (2021) Vol. 86, pp. 110105-110105
Open Access | Times Cited: 11
Chorlada Paiboonrungruang, Emily J. Simpson, Zhaohui Xiong, et al.
Cellular Signalling (2021) Vol. 86, pp. 110105-110105
Open Access | Times Cited: 11
Structure-Based Identification of Kelch-like ECH-Associated Protein 1 as a Pharmacological Target of Electrophile-Containing Catechol-O-Methyltransferase Inhibitors
Ping Wang, Yang Li, Jinyi Yang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 693-706
Closed Access
Ping Wang, Yang Li, Jinyi Yang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 693-706
Closed Access
Targeting nuclear factor erythroid 2-related factor 2-regulated ferroptosis to treat nervous system diseases
Yeqi Huang, Zhengwei Huang, Xuejuan Zhang
World Journal of Clinical Cases (2024) Vol. 12, Iss. 33, pp. 6655-6659
Closed Access
Yeqi Huang, Zhengwei Huang, Xuejuan Zhang
World Journal of Clinical Cases (2024) Vol. 12, Iss. 33, pp. 6655-6659
Closed Access
Acute exposure to LPS induces cardiac dysfunction via the activation of the NLRP3 inflammasome
Tshiamo T. Maluleke, Ashmeetha Manilall, Nandi Shezi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Tshiamo T. Maluleke, Ashmeetha Manilall, Nandi Shezi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Modulation of the KEAP1–NRF2 Pathway for the Treatment of Neurodegenerative Diseases: Rationale, Assay Methodologies, and Reference Compounds
José Clerigué, Jorge Pascual-Guerra, Rafael León, et al.
Neuromethods (2024), pp. 105-135
Closed Access
José Clerigué, Jorge Pascual-Guerra, Rafael León, et al.
Neuromethods (2024), pp. 105-135
Closed Access
Procyanidin B2 Ameliorates Endothelial Dysfunction and Impaired Angiogenesis via the Nrf2/PPARγ/sFlt-1 Axis in Preeclampsia
Lei Liu, Rencheng Wang, Ran Xu, et al.
SSRN Electronic Journal (2021)
Closed Access
Lei Liu, Rencheng Wang, Ran Xu, et al.
SSRN Electronic Journal (2021)
Closed Access